vs

Side-by-side financial comparison of Exodus Movement, Inc. (EXOD) and LIFECORE BIOMEDICAL, INC. \DE\ (LFCR). Click either name above to swap in a different company.

LIFECORE BIOMEDICAL, INC. \DE\ is the larger business by last-quarter revenue ($31.1M vs $29.4M, roughly 1.1× Exodus Movement, Inc.). LIFECORE BIOMEDICAL, INC. \DE\ runs the higher net margin — -32.1% vs -181.0%, a 148.9% gap on every dollar of revenue. On growth, LIFECORE BIOMEDICAL, INC. \DE\ posted the faster year-over-year revenue change (-4.5% vs -34.4%). LIFECORE BIOMEDICAL, INC. \DE\ produced more free cash flow last quarter ($25.0K vs $-25.8M). Over the past eight quarters, Exodus Movement, Inc.'s revenue compounded faster (0.6% CAGR vs -0.1%).

Exodus is a cryptocurrency wallet available on desktop and mobile platforms. It was founded in 2015 by JP Richardson and Daniel Castagnoli. Exodus wallet supports digital assets including Bitcoin, Ethereum, and Solana. It is available on Windows, macOS, Linux, iOS, Android, and as a browser extension.

LIFECORE BIOMEDICAL, INC. is a biomedical firm focused on developing and manufacturing high-quality hyaluronic acid-based biomaterials. It operates three core segments: medical application products, pharmaceutical solutions, and personal care ingredients, with main markets spanning North America, Europe and the Asia-Pacific, supplying to leading medical device, pharmaceutical and cosmetic brand partners.

EXOD vs LFCR — Head-to-Head

Bigger by revenue
LFCR
LFCR
1.1× larger
LFCR
$31.1M
$29.4M
EXOD
Growing faster (revenue YoY)
LFCR
LFCR
+29.9% gap
LFCR
-4.5%
-34.4%
EXOD
Higher net margin
LFCR
LFCR
148.9% more per $
LFCR
-32.1%
-181.0%
EXOD
More free cash flow
LFCR
LFCR
$25.9M more FCF
LFCR
$25.0K
$-25.8M
EXOD
Faster 2-yr revenue CAGR
EXOD
EXOD
Annualised
EXOD
0.6%
-0.1%
LFCR

Income Statement — Q4 FY2025 vs Q2 FY2026

Metric
EXOD
EXOD
LFCR
LFCR
Revenue
$29.4M
$31.1M
Net Profit
$-53.2M
$-10.0M
Gross Margin
25.0%
Operating Margin
-226.9%
-9.9%
Net Margin
-181.0%
-32.1%
Revenue YoY
-34.4%
-4.5%
Net Profit YoY
-179.5%
-52.0%
EPS (diluted)
$-0.29

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
EXOD
EXOD
LFCR
LFCR
Q4 25
$29.4M
Q3 25
$30.3M
$31.1M
Q2 25
$25.8M
Q1 25
$36.0M
$35.2M
Q4 24
$44.8M
$32.6M
Q3 24
$20.1M
$24.7M
Q2 24
$22.3M
Q1 24
$29.1M
$35.7M
Net Profit
EXOD
EXOD
LFCR
LFCR
Q4 25
$-53.2M
Q3 25
$17.0M
$-10.0M
Q2 25
$37.7M
Q1 25
$-12.9M
$-14.8M
Q4 24
$66.9M
$-6.6M
Q3 24
$843.0K
$-16.2M
Q2 24
$-9.6M
Q1 24
$54.8M
$15.6M
Gross Margin
EXOD
EXOD
LFCR
LFCR
Q4 25
Q3 25
25.0%
Q2 25
Q1 25
28.0%
Q4 24
34.0%
Q3 24
43.7%
21.8%
Q2 24
51.7%
Q1 24
63.2%
33.3%
Operating Margin
EXOD
EXOD
LFCR
LFCR
Q4 25
-226.9%
Q3 25
66.9%
-9.9%
Q2 25
Q1 25
-60.4%
-25.7%
Q4 24
-6.0%
Q3 24
-0.3%
-46.9%
Q2 24
-66.1%
Q1 24
-2.5%
Net Margin
EXOD
EXOD
LFCR
LFCR
Q4 25
-181.0%
Q3 25
56.2%
-32.1%
Q2 25
145.8%
Q1 25
-35.8%
-42.0%
Q4 24
149.4%
-20.2%
Q3 24
4.2%
-65.7%
Q2 24
-43.1%
Q1 24
188.5%
43.8%
EPS (diluted)
EXOD
EXOD
LFCR
LFCR
Q4 25
Q3 25
$-0.29
Q2 25
Q1 25
$-0.47
Q4 24
$-0.25
Q3 24
$-0.53
Q2 24
Q1 24
$0.42

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
EXOD
EXOD
LFCR
LFCR
Cash + ST InvestmentsLiquidity on hand
$4.9M
$18.9M
Total DebtLower is stronger
$136.0M
Stockholders' EquityBook value
$247.4M
$-10.5M
Total Assets
$266.8M
$235.2M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
EXOD
EXOD
LFCR
LFCR
Q4 25
$4.9M
Q3 25
$50.5M
$18.9M
Q2 25
$52.9M
Q1 25
$59.8M
$5.4M
Q4 24
$37.9M
$9.5M
Q3 24
$26.5M
Q2 24
$27.8M
Q1 24
$21.0M
Total Debt
EXOD
EXOD
LFCR
LFCR
Q4 25
Q3 25
$136.0M
Q2 25
Q1 25
$124.9M
Q4 24
$111.3M
Q3 24
$106.3M
Q2 24
Q1 24
$97.1M
Stockholders' Equity
EXOD
EXOD
LFCR
LFCR
Q4 25
$247.4M
Q3 25
$296.7M
$-10.5M
Q2 25
$277.1M
Q1 25
$241.5M
$2.2M
Q4 24
$257.5M
$15.4M
Q3 24
$191.2M
$-3.9M
Q2 24
$190.8M
Q1 24
$199.1M
$17.7M
Total Assets
EXOD
EXOD
LFCR
LFCR
Q4 25
$266.8M
Q3 25
$338.5M
$235.2M
Q2 25
$313.7M
Q1 25
$263.2M
$237.7M
Q4 24
$288.0M
$255.4M
Q3 24
$211.6M
$246.8M
Q2 24
$211.6M
Q1 24
$225.4M
$246.2M
Debt / Equity
EXOD
EXOD
LFCR
LFCR
Q4 25
Q3 25
Q2 25
Q1 25
56.05×
Q4 24
7.20×
Q3 24
Q2 24
Q1 24
5.49×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
EXOD
EXOD
LFCR
LFCR
Operating Cash FlowLast quarter
$-25.6M
$1.8M
Free Cash FlowOCF − Capex
$-25.8M
$25.0K
FCF MarginFCF / Revenue
-87.9%
0.1%
Capex IntensityCapex / Revenue
0.9%
5.6%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$-42.3M
$-16.8M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
EXOD
EXOD
LFCR
LFCR
Q4 25
$-25.6M
Q3 25
$-4.8M
$1.8M
Q2 25
$-5.3M
Q1 25
$-6.2M
$1.2M
Q4 24
$-12.0M
$-6.1M
Q3 24
$-4.9M
$-613.0K
Q2 24
$-2.4M
Q1 24
$450.0K
$-1.4M
Free Cash Flow
EXOD
EXOD
LFCR
LFCR
Q4 25
$-25.8M
Q3 25
$-4.8M
$25.0K
Q2 25
$-5.4M
Q1 25
$-6.2M
$-4.3M
Q4 24
$-12.3M
$-8.6M
Q3 24
$-4.9M
$-4.0M
Q2 24
$-2.4M
Q1 24
$300.0K
$-7.8M
FCF Margin
EXOD
EXOD
LFCR
LFCR
Q4 25
-87.9%
Q3 25
-16.0%
0.1%
Q2 25
-20.7%
Q1 25
-17.3%
-12.1%
Q4 24
-27.5%
-26.3%
Q3 24
-24.5%
-16.3%
Q2 24
-10.8%
Q1 24
1.0%
-21.8%
Capex Intensity
EXOD
EXOD
LFCR
LFCR
Q4 25
0.9%
Q3 25
0.1%
5.6%
Q2 25
0.4%
Q1 25
0.1%
15.5%
Q4 24
0.6%
7.5%
Q3 24
0.2%
13.9%
Q2 24
0.2%
Q1 24
0.5%
17.8%
Cash Conversion
EXOD
EXOD
LFCR
LFCR
Q4 25
Q3 25
-0.28×
Q2 25
-0.14×
Q1 25
Q4 24
-0.18×
Q3 24
-5.80×
Q2 24
Q1 24
0.01×
-0.09×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

EXOD
EXOD

Exchange Aggregation$26.6M90%
Other$2.8M10%

LFCR
LFCR

Transferred At Point In Time$26.6M85%
Transferred Over Time$4.5M15%

Related Comparisons